“…The most frequently targeted area is the RCA 19,34,83 and sometimes the CX. The early patency rate of the RGEA was 91.8 to 100% 4,6,13,18,29,32,34,43,50 when used as an in situ graft or as inflow of a composite graft, as shown in Table 1. When the RGEA was used as a free graft, it ranged from 70% to 100%, 33,54,83 as shown in Table 2.…”